Biotécnica Biotecnologia Avançada company information, Employees & Contact Information

BIRAC in pact with Miltenyi Biotec India to boost India's capabilities in cell & gene therapy Times of India

Miltenyi Biotec India and BIRAC Sign Letter of Intent to Advance Indias Cell and Gene Therapy Ecosystem Tribune India

Miltenyi Biotec India and BIRAC Sign Letter of Intent to Advance India’s Cell and Gene Therapy Ecosystem Business Wire India

Miltenyi Biotec and THSTI FIVE partner to launch India’s first hands-on CAR-T cell and gene therapy training curriculum Pharmabiz.com

Miltenyi Biotec India and BIRAC Forge Strategic Alliance to Strengthen India's Cell and Gene Therapy Landscape eHealth Magazine

Miltenyi Biotec, BIRAC partner to boost cell and gene therapy capabilities The Hindu

Miltenyi Biotec and THSTI launch India’s first hands-on clinical cell manufacturing training programme Express Pharma

Miltenyi Biotec’s ZAMTO Cell, claimed to be India's first dual-target CAR-T cancer therapy, expected by 2026 Business Today

Miltenyi Biotec and THSTI to launch India’s first CAR-T Cell and Gene Therapy training curriculum BioSpectrum India

Miltenyi Biotec opens India's first Cell & Gene Therapy center in Hyderabad ET HealthWorld

How Miltenyi Hopes To Help Shape India’s CGT Landscape Citeline News & Insights

Panacea Biotec and Sanofi reached settlement agreement for Shan6 Indian Pharma Post

Miltenyi Biotec inaugurates India’s first cell and gene therapy CoE in Hyderabad BioSpectrum India

Miltenyi Biotec, THSTI collaborate for cell and gene therapy research for cancer care Healthcare Radius

Miltenyi Biotec opens cell and gene therapy CoE in Hyderabad’s Genome Valley The Hindu

Miltenyi Biotec to set up innovation, tech centre in Hyd Times of India

Innovative India Pavilion opens to record attendance at BIO International Convention 2025, Boston BioSpectrum India

Miltenyi Biotec launches India operations, to open Centre in Hyderabad The Economic Times

ICMR and Panacea Biotec begin Phase 3 clinical trial of India's 1st indigenous dengue vaccine DengiAll Mint

Miltenyi Biotec and THSTI collaborate to strengthen R&D in cell and gene therapy BioSpectrum India

Miltenyi Biotec and THSTI Collaborate to Strengthen R&D healthcareexecutive.in

Miltenyi Biotec and Translational Health Science Institute collaborate to strengthen R&D in cell and gene therapy Express Pharma

India's Panacea Biotec to make up to 25 million doses of Sputnik V vaccine Reuters

German firm Miltenyi Biotec opens office, plans Cell and Gene Therapy CoE The Hindu

Panacea Biotec & Sanofi Settle Vaccine Patent Dispute Rediff MoneyWiz

Miltenyi Biotec establishes first India office and CGT Center in Hyderabad Business Today

ICMR and Panacea Biotec announces initiation of Phase 3 clinical trial for a dengue vaccine in India DD News

Panacea Biotec: Making The Vaccine Shift Fortune India

India’s first dengue vaccine moves closer to reality as phase 3 trial enrolment nears completion CNBC TV18

Serum Institute of India sells 0.65% stake in Panacea Biotec, details here CNBC TV18

Historic Deal Signed Between Panacea Biotec and Serum Institute of India PR Newswire

Osmania University signs MoU with Abode Biotec The New Indian Express

Panacea Biotec files suit against Sanofi for patent infringement Mint

Panacea Biotec shares up 5% as phase-3 trial of India's first dengue vaccine 'DengiAll' begins Upstox

Mankind Pharma acquires Panacea Biotec's domestic formulation brands for India and Nepal Business Standard

Serum Institute of India pares stake in Panacea Biotec, stock locked in lower circuit Moneycontrol

Miltenyi Biotec inaugurates India’s first cell and gene therapy centre of excellence in Hyderabad APN News

BioAsia 2024: Miltenyi Biotec launches first office in India, pioneers cell and gene therapy center BizzBuzz